Mark R. Litzow

1993–2025 年に発表

313
論文数
41,883
被引用数
110
h 指数
291
i10 指数

被引用数

Mark R. Litzow の年別被引用数1976 年: 被引用 1 件1986 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 4 件1997 年: 被引用 2 件1999 年: 被引用 5 件2000 年: 被引用 12 件2001 年: 被引用 23 件2002 年: 被引用 22 件2003 年: 被引用 54 件2004 年: 被引用 60 件2005 年: 被引用 80 件2006 年: 被引用 81 件2007 年: 被引用 128 件2008 年: 被引用 159 件2009 年: 被引用 166 件2010 年: 被引用 243 件2011 年: 被引用 210 件2012 年: 被引用 265 件2013 年: 被引用 285 件2014 年: 被引用 267 件2015 年: 被引用 305 件2016 年: 被引用 335 件2017 年: 被引用 301 件2018 年: 被引用 291 件2019 年: 被引用 1,146 件2020 年: 被引用 1,322 件2021 年: 被引用 1,344 件2022 年: 被引用 1,155 件2023 年: 被引用 935 件2024 年: 被引用 1,731 件2025 年: 被引用 829 件2026 年: 被引用 19 件1977〜1985 年は被引用が無いため表示していません1987〜1994 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,754 件、この内訳の 30.1%ドイツ: 引用元論文 1,113 件、この内訳の 7.1%中国: 引用元論文 1,107 件、この内訳の 7%イタリア: 引用元論文 979 件、この内訳の 6.2%イギリス: 引用元論文 907 件、この内訳の 5.8%フランス: 引用元論文 828 件、この内訳の 5.2%スペイン: 引用元論文 541 件、この内訳の 3.4%カナダ: 引用元論文 505 件、この内訳の 3.2%オランダ: 引用元論文 443 件、この内訳の 2.8%オーストラリア: 引用元論文 397 件、この内訳の 2.5%日本: 引用元論文 355 件、この内訳の 2.3%スイス: 引用元論文 313 件、この内訳の 2%
0%30.1%その他 22.4%

分野

  • Medicine80.6%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Immunology and Microbiology4.1%
  • Computer Science0.2%
  • Economics, Econometrics and Finance0.2%
  • Engineering0.2%
  • その他1%

トピック

  • Acute Myeloid Leukemia Research11.1%
  • Acute Lymphoblastic Leukemia research6.8%
  • Hematopoietic Stem Cell Transplantation6.4%
  • Chronic Myeloid Leukemia Treatments5.4%
  • CAR-T cell therapy research4.4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.1%
  • その他61.8%

共著者

全論文

検索で開く
  1. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 被引用: 960

  2. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 1,259

  3. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John C. Byrd - New England Journal of Medicine 2018 被引用: 952

  4. Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 187

  5. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly W. Maloney, Alessandro Rambaldi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Janis Racevskis, Yanming Zhang, Ravi Bhatia, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Wendy Stock, Steven M. Kornblau, Hagop M. Kantarjian, Marina Konopleva, Williams E. Evans, Sima Jeha, Ching‐Hon Pui, Jun J. Yang, Elisabeth Paietta, James R. Downing, Mary V. Relling, Jinghui Zhang, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan - Nature Genetics 2019 被引用: 617

  6. Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 被引用: 738

  7. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Blood 2022 被引用: 237

  8. Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross L. Levine - New England Journal of Medicine 2012 被引用: 1,948

  9. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen, on behalf of the BMT-CTN 1506/MORPHO Study Investigators, Ed Agura, Jessica K. Altman, Achiles Anagnostopoulos, Sarah Anand, Andrew Artz, Walter E. Aulitzky, Sophia Balderman, Karen K. Ballen, Michael W. Becker, Yves Béguin, Leanne Berkahn, Zwi Berneman, Vijaya Raj Bhatt, Ian Bilmon, Francesca Bonifazi, Adrienne Briggs, Benedetto Bruno, Claudio G. Brunstein, Michael Byrne, Jenny Byrne, Mónica Cabrero, Roberto Cairoli, George Carrum, Jan Černý, Yi‐Bin Chen, June‐Won Cheong, Fabio Ciceri, Mercedes Colorado, Rachel J. Cook, Daniel R. Couriel, Charles Craddock, Lloyd E. Damon, Abhinav Deol, Yohan Desbrosses, Steve Devine, Carmela Di Grazia, Antonio Di Stasi, Ajoy Dias, Kathy Dorritie, James Essell, Tetsuya Eto, Sherif S. Farag, Édouard Forcade, Olga Frankfurt, Shin‐ichiro Fujiwara, Takahiro Fukuda, Kentaro Fukushima, Sabine Fürst, Tatsunori Goto, Aric C. Hall, Shunsuke Hatta, Yosr Hicheri, Mitchell E. Horwitz, Hsin‐An Hou, Jonathan How, Dianna S. Howard, Wei‐Hsun Hsu, Anne Huynh, David Irvine, Takayuki Ishikawa ほか 109 名 - Journal of Clinical Oncology 2024 被引用: 185

  10. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2019 被引用: 471

  11. Palliative Care for Patients With Cancer: ASCO Guideline Update

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 被引用: 279

  12. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle A. Elliott, Anjali S. Advani, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Elad Sharon, Richard F. Little, Harry P. Erba, Richard M. Stone, Selina M. Luger, Charles G. Mullighan, Martin S. Tallman - New England Journal of Medicine 2024 被引用: 215

  13. DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

    著者: , , , , , , , , , , , , , , , , , , , , - JAMA 2023 被引用: 144

  14. Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Yin, Steven M. Kornblau, Stephen P. Hunger, Mignon L. Loh, Ching‐Hon Pui, Wenjian Yang, Kristine R. Crews, Kathryn G. Roberts, Jun J. Yang, Mary V. Relling, William E. Evans, Wendy Stock, Elisabeth Paietta, Adolfo A. Ferrando, Jinghui Zhang, Wolfgang Kern, Torsten Haferlach, Gang Wu, John E. Dick, Jeffery M. Klco, Claudia Haferlach, Charles G. Mullighan - Cancer Discovery 2021 被引用: 188

  15. Anthracycline Dose Intensification in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2009 被引用: 907

  16. A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

    著者: , , , , , , , , - Cell Research 2018 被引用: 256

  17. Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deborah A. Freedman-Cass, Mallory Campbell - Journal of the National Comprehensive Cancer Network 2021 被引用: 241

  18. Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Hematology 2023 被引用: 75

  19. High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wendy Stock, Stephen Kornblau, Hagop M. Kantarjian, Marina Konopleva, Elisabeth Paietta, Cheryl L. Willman, Charles G. Mullighan - Journal of Clinical Oncology 2017 被引用: 449

  20. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 168

  21. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Easton, Jinghui Zhang, Junmin Peng, Hongbo Chi, Stanley Pounds, Mary V. Relling, Hiroto Inaba, Xiaofan Zhu, Steven M. Kornblau, Ching‐Hon Pui, Marina Konopleva, David T. Teachey, Charles G. Mullighan, Kimberly Stegmaier, William E. Evans, Jiyang Yu, Jun J. Yang - Nature Cancer 2021 被引用: 157

  22. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

    著者: , , , , , , , , , , , , , - Blood 2006 被引用: 843

  23. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 488

  24. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Vietz, Eric A. Severson, Molly Miller, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy F. Chen, Mona Stefanos, Brian Druker, John C. Byrd - Nature Medicine 2020 被引用: 192